Why Your Surgeon Talks About Risk Scores Before Heart Surgery
When cardiac surgery is on the table, one of the first things your surgical team will do is calculate your estimated operative risk. This is not a formality. Risk scores shape the conversation about whether surgery is the right choice, which procedure to recommend, and what kind of recovery to expect.
Two risk models dominate cardiac surgery worldwide: the STS Predicted Risk of Mortality (STS-PROM), developed in North America, and the EuroSCORE II, developed in Europe and used across much of the rest of the world. If you have seen your risk expressed as a percentage, one or both of these tools was likely involved.
As a cardiac surgeon, I use both models regularly. Each has strengths. Each has limitations. And patients deserve to understand both, because these numbers directly influence the treatment recommendations you receive. This guide focuses on the EuroSCORE II calculator, how it works, what it measures, and how it fits alongside other tools in the decision-making process.
How the EuroSCORE II Calculator Actually Works
The original EuroSCORE (European System for Cardiac Operative Risk Evaluation) was introduced in 1999, based on data from nearly 20,000 patients across 128 hospitals in eight European countries. It was a landmark achievement, but over time it began to overestimate mortality risk, particularly in higher-risk patients, because surgical techniques and perioperative care had improved significantly since the original data was collected.
The EuroSCORE II was released in 2012 to address this. It was recalibrated using data from over 22,000 patients who underwent cardiac surgery in 2010, providing a more contemporary and accurate risk estimate. Unlike the original additive EuroSCORE (which simply added up points), EuroSCORE II uses a logistic regression model that accounts for the way risk factors interact with one another.
What Variables Does EuroSCORE II Include?
The EuroSCORE II calculator evaluates 18 variables grouped into three categories:
- Patient-related factors: Age, sex, kidney function (creatinine clearance), the presence of extracardiac arteriopathy, poor mobility, previous cardiac surgery, chronic lung disease, active endocarditis, critical preoperative state, and whether diabetes requires insulin.
- Cardiac-related factors: NYHA functional class (a measure of heart failure symptoms), CCS class IV angina (unstable angina at rest), left ventricular function, recent myocardial infarction, and pulmonary hypertension.
- Surgery-related factors: Urgency of the procedure, the weight of the intervention (isolated CABG vs. multiple procedures), and whether the thoracic aorta is involved.
The calculator processes these inputs through a mathematical model and produces an estimated percent risk of in-hospital mortality. For example, a result of 2.1% means that among 100 patients with a similar profile, approximately two would be expected not to survive the hospitalization.
It is worth noting that this is a population-level estimate, not a personal guarantee. Your individual risk may be higher or lower depending on factors the model does not capture, such as frailty, nutritional status, or the specific experience of your surgical team.
EuroSCORE vs STS: Understanding the Key Differences
Patients sometimes receive risk estimates from both the EuroSCORE II and the STS score and are understandably confused when the numbers differ. This is common, and it does not mean one score is wrong.
The comparison of EuroSCORE vs STS comes down to several important differences:
- Population base: The STS score is derived from North American surgical data, while EuroSCORE II is based on European data. Differences in patient demographics, referral patterns, and practice standards can influence the baseline risk estimates.
- Granularity: The STS risk calculator uses more variables, roughly 40 or more depending on the procedure, and provides procedure-specific models for isolated CABG, isolated valve surgery, and combined procedures. EuroSCORE II uses fewer variables and a single model for all cardiac surgery types.
- Outcomes predicted: The STS score predicts not only mortality but also major morbidity endpoints such as stroke, renal failure, prolonged ventilation, deep sternal wound infection, and reoperation. EuroSCORE II predicts in-hospital mortality only.
- Calibration: Multiple validation studies, including a 2014 analysis published in the European Journal of Cardio-Thoracic Surgery, have shown that EuroSCORE II performs well for average-risk patients but can overestimate risk in very high-risk populations. The STS score tends to be better calibrated across a broader spectrum of risk, particularly in North American populations.
Neither score is universally superior. In my practice, I calculate both and consider them together. When the scores diverge significantly, that itself becomes useful information, prompting a closer look at which risk factors are driving the difference.
If you want to explore how these scores apply to your own situation, our free cardiac surgery risk calculator can give you a starting point for that conversation with your surgeon.
What the European Cardiac Surgery Risk Score Means for Your Decision
A risk score is a tool, not a verdict. I want to be very clear about this because I have seen patients make fear-based decisions after seeing a number on a screen without understanding the context behind it.
Here is how the European cardiac surgery risk score is typically used in clinical practice:
Surgical Candidacy and Procedure Selection
For patients with aortic stenosis, for example, guidelines from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC) use EuroSCORE II thresholds to help guide the choice between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR). Generally speaking, a EuroSCORE II below 4% may favor SAVR in younger, lower-risk patients, while scores above 4% tilt the discussion toward TAVR, though age, anatomy, and life expectancy all factor in as well.
Heart Team Discussions
In a well-functioning heart team, the risk score is a starting point for a multidisciplinary conversation. Interventional cardiologists, cardiac surgeons, imaging specialists, and anesthesiologists all bring different perspectives. The score provides a common language, but the final recommendation should reflect the full clinical picture, not just a single number.
Informed Consent
You have the right to know your estimated operative risk, and a good surgeon will walk you through what the number means and, equally important, what it does not capture. If your surgeon has not discussed your risk score with you, ask. If the explanation does not make sense, that is a valid reason to seek a second opinion from an independent cardiac surgeon.
Limitations of EuroSCORE II That Patients Should Know
No risk model is perfect, and EuroSCORE II has several known limitations that matter for patients:
- Frailty is not directly measured. Frailty, the clinical syndrome of reduced physiologic reserve, is one of the strongest predictors of poor outcomes after cardiac surgery. EuroSCORE II uses "poor mobility" as a surrogate, but this is a crude approximation. A patient who is sarcopenic and malnourished but can still walk may not be flagged as high-risk by the model.
- It does not account for institutional or surgeon volume. Studies consistently show that outcomes vary based on hospital and surgeon experience. A EuroSCORE II of 5% at a high-volume center with a dedicated intensive care unit may carry very different real-world risk than the same score at a low-volume facility.
- It was not designed for certain newer procedures. EuroSCORE II was calibrated on patients undergoing conventional cardiac surgery. Its accuracy for transcatheter procedures, including TAVR and transcatheter mitral interventions, is debated. Some studies suggest it overestimates mortality in TAVR populations.
- Validation varies by geography. Several studies from Asian and South American populations have shown variable calibration of EuroSCORE II outside of Europe, suggesting that the model may not generalize perfectly to all patient populations.
These limitations do not make the tool useless. They make it incomplete on its own. This is exactly why I encourage patients to look at risk assessment as one piece of a larger decision-making framework, not the whole picture.
What You Should Do With This Information
If you or a family member are facing cardiac surgery and have been given a EuroSCORE II result, here are some practical steps:
- Ask your surgeon to explain the score in context. What are the main factors driving your risk? Are there modifiable factors, such as kidney function or nutritional status, that could be optimized before surgery?
- Ask whether the STS score was also calculated. If only one score was used, request the other. Comparing the two can be informative.
- Understand what the score does and does not predict. EuroSCORE II predicts in-hospital mortality. It does not predict long-term survival, quality of life, stroke risk, or how your recovery will feel at three months or a year.
- Consider the source of the recommendation. A surgeon at a high-volume center may interpret your risk differently than one at a community hospital. This is not about one being wrong; it is about context and experience.
- Get an independent review if anything feels uncertain. A second opinion is not a sign of distrust. It is a standard of care for complex surgical decisions. At WhiteGloveMD, we review your imaging, your risk scores, and your full clinical picture to ensure the recommendation you have received is sound.
Risk scores like EuroSCORE II exist to make surgical decision-making more transparent and evidence-based. But they work best when they are part of a thoughtful, individualized conversation between a patient and a surgeon who takes the time to explain what the numbers mean for you.
If you are facing a cardiac surgery decision and want to understand your risk assessment in full context, a WhiteGloveMD second opinion can help. We review your complete records, including risk scores, imaging, and catheterization data, and provide a detailed, surgeon-authored report with clear recommendations. Because when the stakes are this high, you deserve more than a number on a screen.